BJU International | 2019

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Abstract

To report the safety and efficacy results of patients enrolled in the Italian Nivolumab Renal Cell Cancer Expanded Access Programme.

Volume 123
Pages None
DOI 10.1111/bju.14461
Language English
Journal BJU International

Full Text